The Impact of Pdcd4, a Translation Inhibitor, on Drug Resistance

被引:0
|
作者
Wang, Qing [1 ]
Yang, Hsin-Sheng [1 ,2 ]
机构
[1] Univ Kentucky, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA
[2] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA
关键词
eIF4A; mTORC2-Akt pathway; beta-catenin pathway; JNK pathway; paclitaxel; doxorubicin; fluorouracil; platinum-containing drug; IGF1R/IR inhibitor; SUPPRESSOR PROTEIN PDCD4; NF-KAPPA-B; TRANSFORMATION SUPPRESSOR; CANCER CELLS; DEPENDENT TRANSCRIPTION; EUKARYOTIC TRANSLATION; DOXORUBICIN RESISTANCE; MOLECULAR-MECHANISMS; ARGININE METHYLATION; MAMMALIAN TARGET;
D O I
10.3390/ph17101396
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Programmed cell death 4 (Pdcd4) is a tumor suppressor, which has been demonstrated to efficiently suppress tumorigenesis. Biochemically, Pdcd4 binds with translation initiation factor 4A and represses protein translation. Beyond its role in tumor suppression, growing evidence suggests that Pdcd4 enhances the chemosensitivity of several anticancer drugs. To date, numerous translational targets of Pdcd4 have been identified. These targets govern important signal transduction pathways, and their attenuation may improve chemosensitivity or overcome drug resistance. This review will discuss the signal transduction pathways regulated by Pdcd4 and the potential mechanisms through which Pdcd4 enhances chemosensitivity or counteracts drug resistance.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Epidermal expression of the translation inhibitor Pdcd4 suppresses tumorigenesis.
    Jansen, AP
    Colburn, NH
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (11) : 2714S - 2715S
  • [2] Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion
    Schmid, Tobias
    Jansen, Aaron P.
    Baker, Alyson R.
    Hegamyer, Glenn
    Hagan, John P.
    Colburn, Nancy H.
    CANCER RESEARCH, 2008, 68 (05) : 1254 - 1260
  • [3] The role of Pdcd4 in tumour suppression and protein translation
    Wang, Qing
    Yang, Hsin-Sheng
    BIOLOGY OF THE CELL, 2018, 110 (08) : 169 - 177
  • [4] Inhibition of translation by a novel tumor suppressor, Pdcd4
    Yang, HS
    Merrick, W
    Sonenberg, N
    Colburn, N
    FASEB JOURNAL, 2002, 16 (04): : A560 - A561
  • [5] eIF4A and PDCD4 expression in TNBC underlies sensitivity to natural product translation inhibitor
    Subramanian, Alagu
    Xue, Haoran
    Hull, Kenneth G.
    Romo, Daniel
    Taube, Joseph
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [6] An evolutionarily conserved interaction of tumor suppressor protein Pdcd4 with the poly(A)-binding protein contributes to translation suppression by Pdcd4
    Fehler, Olesja
    Singh, Priyanka
    Haas, Astrid
    Ulrich, Diana
    Mueller, Jan P.
    Ohnheiser, Johanna
    Klempnauer, Karl-Heinz
    NUCLEIC ACIDS RESEARCH, 2014, 42 (17) : 11107 - 11118
  • [7] Structural basis for inhibition of translation by the tumor suppressor Pdcd4
    LaRonde-LeBlanc, Nicole
    Santhanam, Arti N.
    Baker, Alyson R.
    Wlodawer, Alexander
    Colburn, Nancy H.
    MOLECULAR AND CELLULAR BIOLOGY, 2007, 27 (01) : 147 - 156
  • [8] Translation inhibitor PDCD4 promotes CD8+T cell proliferation during antiviral response
    Xie, Xiangfei
    Araki, Koichi
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [9] Proceedings on The Expression of Tumor Suppressor Gene Pdcd4 and Ubiquitin Pathway of Pdcd4 Protein
    Cao Chun-Ming
    Sun Zhen-Xiao
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2010, 37 (04) : 353 - 357
  • [10] Pdcd4 targets eIF4A to inhibit translation, transcription, tumorigenesis, and invasion
    Colburn, Nancy H.
    Yang, Hsin-Sheng
    Jansen, Aaron
    EJC SUPPLEMENTS, 2006, 4 (06): : 23 - 23